Drug Shortage Report for PMS-DICLOFENAC
Report ID | 198008 |
Drug Identification Number | 02302616 |
Brand name | PMS-DICLOFENAC |
Common or Proper name | DICLOFENAC |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 25MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-10 |
Estimated end date | 2023-12-01 |
Actual end date | 2023-11-21 |
Shortage status | Resolved |
Updated date | 2023-11-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-11-30 | French | Compare |
v10 | 2023-11-30 | English | Compare |
v9 | 2023-11-21 | French | Compare |
v8 | 2023-11-21 | English | Compare |
v7 | 2023-11-10 | French | Compare |
v6 | 2023-11-10 | English | Compare |
v5 | 2023-09-18 | French | Compare |
v4 | 2023-09-18 | English | Compare |
v3 | 2023-07-11 | English | Compare |
v2 | 2023-07-10 | French | Compare |
v1 | 2023-07-10 | English | Compare |
Showing 1 to 11 of 11